SOPHiA GENETICSSOPHiA GENETICS was founded in 2011 by biologists who had a vision to create a technology that could make a positive and lasting impact on the world, using data for good. We’ve built a revolutionary technology platform, SOPHiA DDM™, that rapidly distills complex data into actionable insights, enabling clinicians, researchers, and biopharma to reshape the way that we diagnose and treat cancer and rare inherited disorders.
Vendor
SOPHiA GENETICS
Company Website
- SOPHiA DDM for Genomics
Accurately detect and classify variants from complex oncology and rare & inherited disorder data, with information from curated databases and community insights empowering confident decision-making.
- SOPHiA DDM for Multimodal
Integrate longitudinal data from multiple sources and data modalities to generate new insights. Leverage SOPHiA CarePath® for enhanced data visualization, cohorting, and predictive analytics.
- SOPHiA DDM for Radiomics
Gain novel insights through automated, validated image segmentation and feature extraction, with a platform agnostic to 3D imaging modality, equipment, and cancer indication.